Edition:
United Kingdom

Karo Pharma AB (KARO.ST)

KARO.ST on Stockholm Stock Exchange

32.30SEK
21 Sep 2018
Change (% chg)

-0.35kr (-1.07%)
Prev Close
32.65kr
Open
32.65kr
Day's High
32.65kr
Day's Low
32.15kr
Volume
364,648
Avg. Vol
763,533
52-wk High
38.37kr
52-wk Low
25.25kr

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 489.45 3.860
Mar '18 267.06 0.424
FY 2017 Dec '17 238.72 -0.399
Sep '17 137.09 0.128
Jun '17 142.46 0.176
Mar '17 139.33 0.231
FY 2016 Dec '16 96.45 1.276
Sep '16 85.16 0.056
Jun '16 81.91 -0.040
Mar '16 82.30 0.049
 
*Note: Units in Millions ofSwedish Krona
**Note: Units in Swedish Krona

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 423.00 423.00 423.00 --
Quarter Ending Dec-18 1 473.00 473.00 473.00 --
Year Ending Dec-18 1 1,652.00 1,652.00 1,652.00 --
Year Ending Dec-19 1 2,027.00 2,027.00 2,027.00 --
Earnings (per share)
Quarter Ending Sep-18 1 0.26 0.26 0.26 --
Quarter Ending Dec-18 1 0.25 0.25 0.25 --
Year Ending Dec-18 1 4.81 4.81 4.81 --
Year Ending Dec-19 1 2.08 2.08 2.08 --
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 20.39 85.68 32.76
P/E High - Last 5 Yrs. 17.52 300.70 45.44
P/E Low - Last 5 Yrs. 17.52 92.08 24.26
Beta 0.71 0.93 0.89
Price to Sales (TTM) 7.06 114.98 5.74
Price to Book (MRQ) 3.08 15.51 5.00
Price to Tangible Book (MRQ) -- 14.62 6.57
Price to Cash Flow (TTM) 19.20 72.88 23.29
% Owned Institutions -- 14.70 2.21

Dividends

  Company industry sector
Dividend Yield 0.70 0.36 1.51
Dividend Yield - 5 Year Avg 0.35 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) 0.00 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 73.93 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago 100.57 80.36 5.64
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 541.36 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago 278.13 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate 15.70 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 2.25 5.46 3.03
LT Debt to Equity (MRQ) 45.78 35.27 12.51
Total Debt to Equity (MRQ) 45.78 37.09 16.85
Interest Coverage (TTM) -9.49 -102.34 32.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 50.37 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.16
EBITD Margin (TTM) 28.58 -- --
EBITD - 5 Yr. Avg -36.86 -600.62 10.68
Operating Margin (TTM) 20.58 -759.68 4.33
Operating Margin - 5 Yr. Avg. -43.06 -621.65 6.11
Pre-Tax Margin (TTM) 14.24 -733.53 5.18
Pre-Tax Margin - 5 Yr. Avg. -44.64 -627.35 6.51
Net Profit Margin (TTM) 28.74 -734.90 1.48
Net Profit Margin - 5 Yr. Avg. -30.81 -630.40 2.78
Effective Tax Rate (TTM) -101.89 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 6,716,145 23,229,030 860,305,024
Net Income/Employee (TTM) 1,930,536 3,144,146 101,198,978
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.37 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 10.69 -0.15 11.13
Return on Assets - 5 Yr. Avg. -9.05 3.51 12.40
Return on Investment (TTM) 11.70 1.79 14.61
Return on Investment - 5 Yr. Avg. -13.05 2.56 16.13
Return on Equity (TTM) 15.82 3.28 16.33
Return on Equity - 5 Yr. Avg. -18.16 3.43 17.39
  1 Year 3 Year 5 Year
Sales % 402.58 94.73 --
EPS (TTM) % 192.15 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Karo Pharma AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 3.65 -- 99 52
13 Week -2.93 -- 89 66
26 Week 19.15 -- 99 80
52 Week 13.66 -- 99 50
YTD 51.68 -- 99 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.22%
# of Holders: 20
Total Shares Held: 18,437,939
3 Mo. Net Change: 9,070,567
# New Positions: 5
# Closed Positions: 0
# Increased Positions: 14
# Reduced Positions: 2
# Net Buyers: 12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.